FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

5 letters match. Newest first.

  1. Henan Lvyuan Pharmaceutical Co. Ltd.

    FDA warns Henan Lvyuan Pharmaceutical over CGMP failures at its API plant, including water leaks and incomplete batch records.

    High risk
  2. Seema International

    FDA warns Seema International over unclean API equipment, missing stability data, and quality-unit failures after inspection; APIs adulterated.

    High risk
  3. Soliteint Kozmetikai KFT

    Hungarian contract maker Soliteint Kozmetikai failed to test OTC pain-relief drugs and ingredients, FDA says; U.S. production halted.

    High risk
  4. S & J International Enterprises Public Company Limited

    FDA cited S & J International Enterprises for CGMP violations, data integrity failures, and limiting access to records during a drug inspection.

    High risk
  5. Sanitizer Supply LLC

    FDA warns Sanitizer Supply LLC that its hand sanitizer wipes and sanitizers lacked required potency and microbial testing before release.

    High risk